Get started
Compugen Ltd.Compugen Ltd.Compugen Ltd.

Compugen Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

CGEN chart


Full chart

CGEN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪153.36 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.16 USD
Net income (FY)
‪−14.23 M‬ USD
Revenue (FY)
‪27.86 M‬ USD
Shares float
‪91.53 M‬
Beta (1Y)
1.57

Employees


Employees (FY)
74
Change (1Y)
+6 +8.82%
Revenue / Employee (1Y)
‪376.54 K‬ USD
Net income / Employee (1Y)
‪−192.31 K‬ USD

About Compugen Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Anat Cohen-Dayag
Website
cgen.com
Headquarters
Holon
Founded
1993
ISIN
IL0010852080
FIGI
BBG000B9ZLB0
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Check out other big names from the same industry as CGEN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CGEN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CGEN is 1.70 USD — it has increased by 4.29% in the past 24 hours. Watch Compugen Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Compugen Ltd. stocks are traded under the ticker CGEN.
CGEN stock has risen by 4.29% compared to the previous week, the month change is a 15.65% rise, over the last year Compugen Ltd. has showed a −13.27% decrease.
We've gathered analysts' opinions on Compugen Ltd. future price: according to them, CGEN price has a max estimate of 10.00 USD and a min estimate of 4.00 USD. Watch CGEN chart and read a more detailed Compugen Ltd. stock forecast: see what analysts think of Compugen Ltd. and suggest that you do with its stocks.
CGEN reached its all-time high on Aug 26, 2020 with the price of 19.90 USD, and its all-time low was 0.34 USD and was reached on Nov 24, 2008. View more price dynamics on CGEN chart.
See other stocks reaching their highest and lowest prices.
CGEN stock is 10.84% volatile and has beta coefficient of 1.57. Track Compugen Ltd. stock price on the chart and check out the list of the most volatile stocks — is Compugen Ltd. there?
Today Compugen Ltd. has the market capitalization of ‪152.43 M‬, it has decreased by −0.60% over the last week.
Yes, you can track Compugen Ltd. financials in yearly and quarterly reports right on TradingView.
Compugen Ltd. is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
CGEN earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.06 USD resulting in a −45.45% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Compugen Ltd. earnings.
Compugen Ltd. revenue for the last quarter amounts to ‪2.28 M‬ USD, despite the estimated figure of ‪3.19 M‬ USD. In the next quarter, revenue is expected to reach ‪3.95 M‬ USD.
CGEN net income for the last quarter is ‪−7.18 M‬ USD, while the quarter before that showed ‪−6.12 M‬ USD of net income which accounts for −17.39% change. Track more Compugen Ltd. financial stats to get the full picture.
No, CGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2025, the company has 74 employees. See our rating of the largest employees — is Compugen Ltd. on this list?
Like other stocks, CGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Compugen Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Compugen Ltd. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Compugen Ltd. stock shows the sell signal. See more of Compugen Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.